国际口腔医学杂志

国际口腔医学杂志 ›› 2020, Vol. 47 ›› Issue (2): 131-137.doi: 10.7518/gjkq.2020034

• 牙周专栏 • 上一篇    下一篇

益生菌生态调节在牙周病防治中的应用

刘琳,周婕妤,吴亚菲,赵蕾()   

  1. 口腔疾病研究国家重点实验室 国家口腔疾病临床医学研究中心四川大学华西口腔医院牙周病科 成都 610041
  • 收稿日期:2019-07-14 修回日期:2019-12-06 出版日期:2020-03-01 发布日期:2020-03-12
  • 通讯作者: 赵蕾
  • 作者简介:刘琳,住院医师,硕士,Email： 1040012620@qq.com
  • 基金资助:
    国家自然科学基金(81371150);国家自然科学基金(81771077);四川省重点研发项目(2018SZ0161)

Application of probiotic ecological regulation in prevention and treatment of periodontal diseases

Liu Lin,Zhou Jieyu,Wu Yafei,Zhao Lei()   

  1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Periodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
  • Received:2019-07-14 Revised:2019-12-06 Online:2020-03-01 Published:2020-03-12
  • Contact: Lei Zhao
  • Supported by:
    This study was supported by National Natural Science Foundation of China(81371150);This study was supported by National Natural Science Foundation of China(81771077);Key Research and Development Project of Sichuan Province(2018SZ0161)

RichHTML

51

PDF (PC)

601

摘要：

牙周病的始动因子为菌斑生物膜,近年来菌斑学说越来越倾向于牙周微生态失调。目前牙周病经典的治疗方法为机械性去除菌斑,但疗效存在个体差异性,部分患者需要辅助其他治疗方法。益生菌具有重建宿主微生物群落、调节免疫炎症反应的特点,可能起到改善牙周病微生态的作用。本文从牙周相关疾病分类角度,对目前益生菌生态调节在牙周炎、牙龈炎、口腔异味及种植体周围疾病防治上的临床效应、作用机制及临床应用加以总结。

关键词: 牙周病, 益生菌, 临床效应, 机制, 临床应用

Abstract:

The initiating factor of periodontal diseases is plaque biofilm. In recent years, plaque hypothesis becomes increasingly inclined to the disruption of microbial homeostasis. Classic treatment method is mechanical plaque removal. However, individual differences exist in the curative effect, and some patients need to be assisted with other treatment methods. The role of probiotics in reconstructing host microbial community and regulating immune inflammatory responses may result in certain improvement in the microecology of periodontal diseases. This review summarises the clinical effects, mechanism and clinical application of probiotics for prevention and treatment of periodontitis, gingivitis, oral malodour and periimplant diseases from the perspective of the classification of periodontal diseases.

Key words: periodontal diseases, probiotics, clinical effect, mechanism, clinical application

中图分类号: 

  • R781.4
[1] Marsh PD . Are dental diseases examples of ecolo-gical catastrophes[J]. Microbiology (Reading, Engl), 2003,149(Pt 2):279-294.
[2] Graziani F, Karapetsa D, Alonso B , et al. Nonsurgical and surgical treatment of periodontitis: how many options for one disease[J]. Periodontol 2000, 2017,75(1):152-188.
[3] Mombelli A . Microbial colonization of the perio-dontal pocket and its significance for periodontal therapy[J]. Periodontol 2000, 2018,76(1):85-96.
[4] Roberts FA, Darveau RP . Microbial protection and virulence in periodontal tissue as a function of poly-microbial communities: symbiosis and dysbiosis[J]. Periodontol 2000, 2015,69(1):18-27.
[5] Food and Agricultural Organization of the United Nations and World Health Organization. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria[R].[2001- 10-4]. https://www.iqb.es/digestivo/pdfs/probioticos.pdf. [2019-12-2].
[6] Allaker RP, Ian Douglas CW . Non-conventional the-rapeutics for oral infections[J]. Virulence, 2015,6(3):196-207.
[7] Pamer EG . Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens[J]. Science, 2016,352(6285):535-538.
[8] Tekce M, Ince G, Gursoy H , et al. Clinical and mi-crobiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1-year follow-up study[J]. J Clin Periodontol, 2015,42(4):363-372.
[9] Szkaradkiewicz AK, Stopa J, Karpiński TM . Effect of oral administration involving a probiotic strain of Lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic periodontitis[J]. Arch Immunol Ther Exp (Warsz), 2014,62(6):495-500.
[10] İnce G, Gürsoy H, İpçi ŞD , et al. Clinical and bio-chemical evaluation of lozenges containing Laacto-bacillus reuteri as an adjunct to non-surgical perio-dontal therapy in chronic periodontitis[J]. J Perio-dontol, 2015,86(6):746-754.
[11] Vivekananda MR, Vandana KL, Bhat KG . Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial[J]. J Oral Microbiol, 2010. doi: 10.3402/jom.v2i0.5344.
[12] Teughels W, Durukan A, Ozcelik O , et al. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study[J]. J Clin Pe-riodontol, 2013,40(11):1025-1035.
[13] Penala S, Kalakonda B, Pathakota KR , et al. Efficacy of local use of probiotics as an adjunct to scaling and root planing in chronic periodontitis and halitosis: a randomized controlled trial[J]. J Res Pharm Pract, 2016,5(2):86-93.
[14] Martin-Cabezas R, Davideau JL, Tenenbaum H , et al. Clinical efficacy of probiotics as an adjunctive therapy to non-surgical periodontal treatment of chro-nic periodontitis: a systematic review and meta-analysis[J]. J Clin Periodontol, 2016,43(6):520-530.
[15] Ikram S, Hassan N, Raffat MA , et al. Systematic review and meta-analysis of double-blind, placebo-controlled, randomized clinical trials using probiotics in chronic periodontitis[J]. J Investig Clin Dent, 2018,9(3):e12338.
[16] Morales A, Carvajal P, Silva N , et al. Clinical effects of Lactobacillus rhamnosus in non-surgical treatment of chronic periodontitis: a randomized placebo-controlled trial with 1-year follow-up[J]. J Periodontol, 2016,87(8):944-952.
[17] Morales A, Gandolfo A, Bravo J , et al. Microbiolo-gical and clinical effects of probiotics and antibiotics on nonsurgical treatment of chronic periodontitis: a randomized placebo-controlled trial with 9-month follow-up[J]. J Appl Oral Sci, 2018,26:e20170075.
[18] Invernici MM, Salvador SL, Silva PHF , et al. Effects of Bifidobacterium probiotic on the treatment of chronic periodontitis: a randomized clinical trial[J]. J Clin Periodontol, 2018,45(10):1198-1210.
[19] Pérez-Chaparro PJ, McCulloch JA, Mamizuka EM , et al. Do different probing depths exhibit striking differences in microbial profiles[J]. J Clin Perio-dontol, 2018,45(1):26-37.
[20] Iniesta M, Herrera D, Montero E , et al. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial[J]. J Clin Periodontol, 2012,39(8):736-744.
[21] Sabatini S, Lauritano D, Candotto V , et al. Oral probiotics in the management of gingivitis in diabetic patients: a double blinded randomized controlled study[J]. J Biol Regul Homeost Agents, 2017,31(2 Suppl 1):197-202.
[22] Kuru BE, Laleman I, Yalnızoğlu T , et al. The in-fluence of a Bifidobacterium animalis probiotic on gingival health: a randomized controlled clinical trial[J]. J Periodontol, 2017,88(11):1115-1123.
[23] Montero E, Iniesta M, Rodrigo M , et al. Clinical and microbiological effects of the adjunctive use of probiotics in the treatment of gingivitis: a rando-mized controlled clinical trial[J]. J Clin Periodontol, 2017,44(7):708-716.
[24] Trombelli L, Farina R, Silva CO , et al. Plaque-in-duced gingivitis: case definition and diagnostic considerations[J]. J Clin Periodontol, 2018,45(S20):S44-S67.
[25] Petersilka GJ, Ehmke B, Flemmig TF . Antimicrobial effects of mechanical debridement[J]. Periodontol 2000, 2002,28:56-71.
[26] Keller MK, Bardow A, Jensdottir T , et al. Effect of chewing gums containing the probiotic bacterium Lactobacillus reuteri on oral malodour[J]. Acta Odontol Scand, 2012,70(3):246-250.
[27] Suzuki N, Yoneda M, Tanabe K , et al. Lactobacillus salivarius WB21—containing tablets for the treat-ment of oral malodor: a double-blind, randomized, pla-cebo-controlled crossover trial[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2014,117(4):462-470.
[28] Derks J, Tomasi C . Peri-implant health and disease. A systematic review of current epidemiology[J]. J Clin Periodontol, 2015,42(Suppl 16):S158-S171.
[29] Flichy-Fernández AJ, Ata-Ali J, Alegre-Domingo T , et al. The effect of orally administered probiotic Lac-tobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial[J]. J Periodont Res, 2015,50(6):775-785.
[30] Tada H, Masaki C, Tsuka S , et al. The effects of Lac-tobacillus reuteri probiotics combined with azithro-mycin on peri-implantitis: a randomized placebo-controlled study[J]. J Prosthodont Res, 2018,62(1):89-96.
[31] Hallström H, Lindgren S, Widén C , et al. Probiotic supplements and debridement of peri-implant mucositis: a randomized controlled trial[J]. Acta Odontol Scand, 2016,74(1):60-66.
[32] Teughels W, Loozen G, Quirynen M . Do probiotics offer opportunities to manipulate the periodontal oral microbiota[J]. J Clin Periodontol, 2011,38(Suppl 11):159-177.
[33] Suzuki N, Higuchi T, Nakajima M , et al. Inhibitory effect of Enterococcus faecium WB2000 on volatile sulfur compound production by Porphyromonas gingivalis[J]. Int J Dent, 2016,2016:8241681.
[34] Haukioja A, Loimaranta V, Tenovuo J . Probiotic bacteria affect the composition of salivary pellicle and streptococcal adhesion in vitro[J]. Oral Microbiol Immunol, 2008,23(4):336-343.
[35] Ciandrini E, Campana R, Casettari L , et al. Characte-rization of biosurfactants produced by Lactobacillus spp. and their activity against oral streptococci bio-film[J]. Appl Microbiol Biotechnol, 2016,100(15):6767-6777.
[36] Jones SE, Versalovic J . Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflamma-tory factors[J]. BMC Microbiol, 2009,9(1):35.
[37] Braathen G, Ingildsen V, Twetman S , et al. Presence of Lactobacillus reuteri in saliva coincide with higher salivary IgA in young adults after intake of probiotic lozenges[J]. Benef Microbes, 2017,8(1):17-22.
[38] Castiblanco GA, Yucel-Lindberg T, Roos S , et al. Effect of Lactobacillus reuteri on cell viability and PGE2 production in human gingival fibroblasts[J]. Probiotics Antimicrob Proteins, 2017,9(3):278-283.
[39] Mottet C, Michetti P . Probiotics: wanted dead or alive[J]. Dig Liver Dis, 2005,37(1):3-6.
[40] Zawistowska-Rojek A, Tyski S . Are probiotic really safe for humans[J]. Pol J Microbiol, 2018,67(3):251-258.
[1] 古丽其合热·阿布来提,秦旭,朱光勋. 线粒体自噬在牙周炎发生发展过程中的研究进展[J]. 国际口腔医学杂志, 2024, 51(1): 68-73.
[2] 夏溦瑶,贾仲林. 维生素与唇腭裂发生相关性的研究进展[J]. 国际口腔医学杂志, 2023, 50(6): 632-638.
[3] 于乐蓉,李祥伟,艾虹. 牙髓干细胞干性维持的研究进展[J]. 国际口腔医学杂志, 2023, 50(4): 463-471.
[4] 吴嘉馨,程兴群,吴红崑. 透明质酸在修复龈乳头退缩中的临床应用进展[J]. 国际口腔医学杂志, 2023, 50(3): 347-352.
[5] 王婧妍,秦满,王欣. Axenfeld-Rieger综合征的口腔颌面部临床特点及相关成对同源结构域转录因子2基因突变的致病机制研究进展[J]. 国际口腔医学杂志, 2023, 50(2): 224-229.
[6] 成益凡,秦旭,姜鸣,朱光勋. 牙周病中固有淋巴细胞的研究进展[J]. 国际口腔医学杂志, 2023, 50(1): 32-36.
[7] 李伟光,吴亚菲,郭淑娟. 无机纳米粒子在牙周病诊疗中的研究进展[J]. 国际口腔医学杂志, 2022, 49(6): 724-730.
[8] 龚涛,李雨庆,周学东. 变异链球菌糖转运及其调控机制的研究进展[J]. 国际口腔医学杂志, 2022, 49(5): 506-510.
[9] 赵曼竹,宋锦璘. 时钟基因在牙齿发育中表达分布与调控机制的研究进展[J]. 国际口腔医学杂志, 2022, 49(4): 380-385.
[10] 王冠儒,冯强. 牙龈卟啉单胞菌在阿尔兹海默症发生中作用的研究进展[J]. 国际口腔医学杂志, 2022, 49(4): 397-403.
[11] 雷彬,陈柯. 牙本质发育不良Ⅰ型及其分型治疗[J]. 国际口腔医学杂志, 2022, 49(3): 332-336.
[12] 李归平,秦旭,朱光勋. 腺苷酸活化蛋白激酶在牙周病发生发展中的研究进展[J]. 国际口腔医学杂志, 2022, 49(3): 343-348.
[13] 李俊霖,肖立伟. 隐形矫治技术推磨牙远移机制与疗效的研究进展[J]. 国际口腔医学杂志, 2022, 49(1): 109-115.
[14] 穆新月,刘树泰. 动机性访谈在牙周病患者临床管理中的应用进展[J]. 国际口腔医学杂志, 2022, 49(1): 94-99.
[15] 白皓亮,杨禾,赵蕾. 牙周病风险评估及预后判断工具的研究进展[J]. 国际口腔医学杂志, 2021, 48(6): 696-702.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 张新春. 桩冠修复与无髓牙的保护[J]. 国际口腔医学杂志, 1999, 26(06): .
[2] 王昆润. 长期单侧鼻呼吸对头颅发育有不利影响[J]. 国际口腔医学杂志, 1999, 26(05): .
[3] 彭国光. 颈淋巴清扫术中颈交感神经干的解剖变异[J]. 国际口腔医学杂志, 1999, 26(05): .
[4] 杨凯. 淋巴化疗的药物运载系统及其应用现状[J]. 国际口腔医学杂志, 1999, 26(05): .
[5] 康非吾. 种植义齿下部结构生物力学研究进展[J]. 国际口腔医学杂志, 1999, 26(05): .
[6] 柴枫. 可摘局部义齿用Co-Cr合金的激光焊接[J]. 国际口腔医学杂志, 1999, 26(04): .
[7] 孟姝,吴亚菲,杨禾. 伴放线放线杆菌产生的细胞致死膨胀毒素及其与牙周病的关系[J]. 国际口腔医学杂志, 2005, 32(06): 458 -460 .
[8] 费晓露,丁一,徐屹. 牙周可疑致病菌对口腔黏膜上皮的粘附和侵入[J]. 国际口腔医学杂志, 2005, 32(06): 452 -454 .
[9] 赵兴福,黄晓晶. 变形链球菌蛋白组学研究进展[J]. 国际口腔医学杂志, 2008, 35(S1): .
[10] 庞莉苹,姚江武. 抛光和上釉对陶瓷表面粗糙度、挠曲强度及磨损性能的影响[J]. 国际口腔医学杂志, 2008, 35(S1): .